News of the WeekGenomics

A Second Private Genome Project

See allHide authors and affiliations

Science  21 Aug 1998:
Vol. 281, Issue 5380, pp. 1121
DOI: 10.1126/science.281.5380.1121a

You are currently viewing the summary.

View Full Text

Log in to view the full text

Log in through your institution

Log in through your institution

Summary

Incyte Pharmaceuticals, Inc., a genetic data company in Palo Alto, California, announced this week that it plans to invest $200 million over the next 2 years to sequence the protein coding regions of the human genome. It will also hunt for simple variations in the genetic code--also known as single nucleotide polymorphisms, or SNPs--and locate them and about 100,000 human genes on a computerized map. These data will be kept in a proprietary trove, available only to those willing to pay Incyte's stiff fees. This project could rival the controversial sequencing and SNP-collection effort announced earlier this year by Perkin-Elmer Corp. of Norwalk, Connecticut, and J. Craig Venter of The Institute for Genomic Research (Science, 15 May, p. 994).